Published in J Pediatr on January 01, 1998
Use of atorvastatin in systemic lupus erythematosus in children and adolescents. Arthritis Rheum (2012) 2.37
Cardiovascular disease in systemic lupus erythematosus: the role of traditional and lupus related risk factors. Curr Cardiol Rev (2008) 1.02
Cardiac dysfunction in patients with systemic lupus erythematosus and antiphospholipid syndrome. Ann Rheum Dis (2006) 0.91
Increased risk of death in pediatric and adult patients with ESRD secondary to lupus. Pediatr Nephrol (2010) 0.91
Metabolic abnormalities and cardiovascular risk factors in children with myositis. J Pediatr (2009) 0.81
Absence of Chlamydia pneumoniae and signs of atherosclerotic cardiovascular disease in adolescents with systemic lupus erythematosus. Pediatr Cardiol (2007) 0.77
Contributions of mass spectrometry-based proteomics to defining cellular mechanisms and diagnostic markers for systemic lupus erythematosus. Arthritis Res Ther (2012) 0.75
Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. N Engl J Med (2000) 4.76
Angiographic classification of the isolated, persistently patent ductus arteriosus and implications for percutaneous catheter occlusion. Am J Cardiol (1989) 4.69
Transcatheter occlusion of the persistently patent ductus arteriosus. Forty-month follow-up and prevalence of residual shunting. Circulation (1991) 3.90
Aortic dissection after stent dilatation for coarctation of the aorta: a case report and literature review. Catheter Cardiovasc Interv (2003) 2.82
CACP, encoding a secreted proteoglycan, is mutated in camptodactyly-arthropathy-coxa vara-pericarditis syndrome. Nat Genet (1999) 2.60
Portacaval shunt in patients with familial hypercholesterolemia. Ann Surg (1983) 2.33
Complications associated with pediatric cardiac catheterization. J Am Coll Cardiol (1998) 2.32
Close relationship between systemic lupus erythematosus and thrombotic thrombocytopenic purpura in childhood. Arthritis Rheum (1999) 2.23
Providing after-hours on-call clinical coverage in academic health sciences centres: the Hospital for Sick Children experience. CMAJ (2000) 2.20
Outcome of coronary artery aneurysms after Kawasaki disease. J Pediatr (1992) 2.03
ABO-incompatible heart transplantation in infants. N Engl J Med (2001) 2.01
Stenting of the right ventricular outflow tract in the symptomatic infant with tetralogy of Fallot. Heart (2008) 1.99
Chinese Hemophilia Joint Health Score 2.1 reliability study. Haemophilia (2013) 1.98
Long-term outcome and prognostic determinants in children with hypertrophic cardiomyopathy. J Am Coll Cardiol (1998) 1.92
Clinical features and outcome of pediatric Wegener's granulomatosis. Arthritis Rheum (2007) 1.91
Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis. Arthritis Rheum (2000) 1.91
The modified Blalock-Taussig shunt: clinical impact and morbidity in Fallot's tetralogy in the current era. J Thorac Cardiovasc Surg (1997) 1.78
Dilated cardiomyopathy with neutropenia, short stature, and abnormal carnitine metabolism. J Pediatr (1988) 1.76
Evolving strategies and improving outcomes of the modified norwood procedure: a 10-year single-institution experience. Ann Thorac Surg (2001) 1.67
Iliofemoral arterial complications of balloon angioplasty for systemic obstructions in infants and children. Circulation (1990) 1.65
Arthropathy in thalassaemia patients receiving deferiprone. Lancet (1994) 1.62
Sensitivity of the Systemic Lupus Erythematosus Disease Activity Index, British Isles Lupus Assessment Group Index, and Systemic Lupus Activity Measure in the evaluation of clinical change in childhood-onset systemic lupus erythematosus. Arthritis Rheum (1999) 1.59
Repair of coarctation of the aorta in children: postoperative morphology. Radiology (1991) 1.58
Physeal involvement in chronic recurrent multifocal osteomyelitis. Pediatr Radiol (1989) 1.57
Morphologic and hemodynamic consequences after percutaneous balloon valvotomy for neonatal pulmonary stenosis: medium-term follow-up. J Am Coll Cardiol (1996) 1.57
Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies: I. Physician, parent, and patient global assessments. Juvenile Dermatomyositis Disease Activity Collaborative Study Group. Arthritis Rheum (1997) 1.55
Intravenous immunoglobulin therapy in a child with cutaneous polyarteritis nodosa. Clin Exp Rheumatol (1998) 1.54
Distribution and natural history of stress fractures in U.S. Marine recruits. Radiology (1983) 1.53
Scimitar syndrome in infancy. J Am Coll Cardiol (1993) 1.52
Early predictors of poor functional outcome in systemic-onset juvenile rheumatoid arthritis: a multicenter cohort study. Arthritis Rheum (2000) 1.52
Endovascular stents in the pulmonary circulation. Clinical impact on management and medium-term follow-up. Circulation (1995) 1.52
Pediatric onset of Behçet's syndrome with myositis: case report and literature review illustrating unusual features. Arthritis Rheum (1990) 1.51
Recognition and management of Kawasaki disease. CMAJ (2000) 1.51
Transcatheter perforation of the right ventricular outflow tract as initial therapy for pulmonary valve atresia and intact ventricular septum in the newborn. Cathet Cardiovasc Diagn (1997) 1.49
Increased anticardiolipin antibody IgG titers do not predict recurrent stroke or TIA in children. Neurology (2004) 1.49
Pre-closure of femoral venous access sites used for large-sized sheath insertion with the Perclose device in adults undergoing cardiac intervention. Heart (2006) 1.49
An international consensus survey of the diagnostic criteria for juvenile dermatomyositis (JDM). Rheumatology (Oxford) (2006) 1.49
Methotrexate-nonsteroidal antiinflammatory drug interaction in children with arthritis. J Rheumatol (1990) 1.48
Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort: ethnicity as a risk factor. Arthritis Rheum (2007) 1.48
Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis. Rheumatology (Oxford) (2006) 1.47
Autologous stem cell transplantation for pediatric rheumatic diseases. J Rheumatol (2001) 1.45
Procedure guideline for radionuclide cystography in children. Society of Nuclear Medicine. J Nucl Med (1997) 1.45
Intravenous immunoglobulin therapy: magic or black magic. J Rheumatol Suppl (1992) 1.44
Regional ventricular wall motion abnormalities in tricuspid atresia after the Fontan procedure. J Am Coll Cardiol (1993) 1.42
Stenting of coronary artery stenosis in Kawasaki disease. Catheter Cardiovasc Interv (1999) 1.41
Quality of randomized clinical trials in juvenile idiopathic arthritis. Rheumatology (Oxford) (2008) 1.40
Subaortic stenosis, the univentricular heart, and banding of the pulmonary artery: an analysis of the courses of 43 patients with univentricular heart palliated by pulmonary artery banding. Circulation (1986) 1.40
Right-to-left shunt following repair of partial anomalous pulmonary venous connection: a novel use of the Rashkind double-umbrella occlusion device. Cathet Cardiovasc Diagn (1994) 1.39
Catheter occlusion of the persistently patent ductus arteriosus. Am J Cardiol (1988) 1.38
Clinical images: Pachydermodactyly. Arthritis Rheum (2005) 1.38
Chronic recurrent multifocal osteomyelitis: a noninfectious inflammatory process. Pediatr Infect Dis J (1987) 1.37
Validation of Doppler-derived pulmonary arterial pressure in patients with ductus arteriosus under different hemodynamic states. Circulation (1987) 1.36
Endovascular stents in the management of coarctation of the aorta in the adolescent and adult: one year follow up. Heart (2001) 1.35
The camptodactyly-arthropathy-coxa vara-pericarditis syndrome: clinical features and genetic mapping to human chromosome 1. Arthritis Rheum (1998) 1.35
Two-dimensional echocardiographic and color flow Doppler evaluation of ductal occlusion with the Rashkind prosthesis. Circulation (1989) 1.34
Intravascular stent prosthesis for right ventricular outflow obstruction. J Am Coll Cardiol (1992) 1.33
Echocardiographic follow-up of atrial septal defect after catheter closure by double-umbrella device. Circulation (1993) 1.33
Extracardiac conduit versus lateral tunnel cavopulmonary connections at a single institution: impact on outcomes. J Thorac Cardiovasc Surg (2001) 1.31
The futility of bone scanning in neonatal osteomyelitis: concise communication. J Nucl Med (1980) 1.30
Neuropsychiatric involvement in pediatric systemic lupus erythematosus. Lupus (2007) 1.30
Validation of the Childhood Health Assessment Questionnaire in the juvenile idiopathic myopathies. Juvenile Dermatomyositis Disease Activity Collaborative Study Group. J Rheumatol (2001) 1.29
Tissue plasminogen activator for the treatment of thromboembolism in infants and children. J Pediatr (1991) 1.26
Thrombolytic therapy for femoral artery thrombosis after pediatric cardiac catheterization. Am Heart J (1988) 1.25
Tubulointerstitial nephritis and uveitis in children and adolescents. Four new cases and a review of the literature. Pediatr Nephrol (1999) 1.24
Treatment of dermatomyositis with intravenous gammaglobulin. Am J Med (1991) 1.24
Predictors of disease course and remission in systemic juvenile idiopathic arthritis: significance of early clinical and laboratory features. Arthritis Rheum (2006) 1.22
Impact of dynamic 3D transoesophageal echocardiography in the assessment of atrial septal defects and occlusion by the double-umbrella device (CardioSEAL) Cardiol Young (1998) 1.22
MR imaging and angiography of primary CNS vasculitis of childhood. AJNR Am J Neuroradiol (2006) 1.21
Safety and outcomes of thrombolysis with tissue plasminogen activator for treatment of intravascular thrombosis in children. J Pediatr (2001) 1.20
Consumption coagulopathy associated with systemic juvenile rheumatoid arthritis. J Pediatr (1983) 1.19
Where's the evidence? Putting clinical science into pediatric rheumatology. J Rheumatol (1996) 1.18
The Cutaneous Assessment Tool: development and reliability in juvenile idiopathic inflammatory myopathy. Rheumatology (Oxford) (2007) 1.18
Balloon dilatation for superior vena caval obstruction after the senning procedure. Cathet Cardiovasc Diagn (1985) 1.18
The clinical meaning of functional outcome scores in children with juvenile arthritis. Arthritis Rheum (2001) 1.18
Localized scleroderma in childhood: a report of 30 cases. Semin Arthritis Rheum (1994) 1.17
Prevalence, risk factors, and outcome of uveitis in juvenile idiopathic arthritis: a long-term followup study. Arthritis Rheum (2007) 1.16
Intravenous immunoglobulin in the treatment of polyarticular juvenile rheumatoid arthritis: a phase I/II study. Pediatric Rheumatology Collaborative Study Group. J Rheumatol (1996) 1.16
The effectiveness of treating juvenile dermatomyositis with methotrexate and aggressively tapered corticosteroids. Arthritis Rheum (2005) 1.13
Diagnosis of osteomyelitis in children by combined blood pool and bone imaging. Radiology (1975) 1.12
Chronic recurrent multifocal osteomyelitis and psoriasis--a report of a new association and review of related disorders. Semin Arthritis Rheum (1988) 1.12
Neurologic manifestations of pediatric systemic lupus erythematosus. Pediatr Neurol (1995) 1.11
Risk factors for development of uveitis differ between girls and boys with juvenile idiopathic arthritis. Arthritis Rheum (2010) 1.11